Jefferies Financial Group’s Capricor Therapeutics CAPR Stock Holding History
Bought
Maintained
Sold
Other funds holding CAPR
Jefferies Financial Group's CAPR Position: Q3 2026 in Review
Jefferies Financial Group sold out of Capricor Therapeutics (CAPR) in Q3 2026, closing a stake of 105,755 shares — an estimated $2.55M sold.
Jefferies Financial Group first reported a position in CAPR in Q1 2024 and held it in 3 quarters. The position peaked at $3.17M in Q1 2026. 158 funds tracked by Wall St. Rank hold CAPR as of Q3 2026.
- Jefferies Financial Group reported no remaining Capricor Therapeutics position as of Q3 2026 after selling out during the quarter.
- Jefferies Financial Group sold 105,755 Capricor Therapeutics shares in Q3 2026, an estimated $2.55M.
- Jefferies Financial Group first reported a position in Capricor Therapeutics in Q1 2024 and held it in 3 quarters.
- Jefferies Financial Group's Capricor Therapeutics position peaked at $3.17M in Q1 2026.
- 158 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q3 2026.
Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.